DarioHealth Corp. Revenue from Contract with Customer, Including Assessed Tax
DarioHealth Corp. (DRIO) reported Revenue from Contract with Customer, Including Assessed Tax of $5.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-11
- DarioHealth Corp. revenue from contract with customer, including assessed tax for the quarter ending 2026-06-30 was $5.18M, a 3.58% decline year-over-year.
- DarioHealth Corp. revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $5.58M, a 17.30% decline year-over-year.
- DarioHealth Corp. revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $5.23M, a 31.21% decline year-over-year.
- DarioHealth Corp. revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $5.01M, a 32.55% decline year-over-year.
- DarioHealth Corp. revenue from contract with customer, including assessed tax for fiscal 2025 was $22.36M, a 17.31% decline from fiscal 2024.
- DarioHealth Corp. revenue from contract with customer, including assessed tax for fiscal 2024 was $27.04M, a 32.86% increase from fiscal 2023.
- DarioHealth Corp. revenue from contract with customer, including assessed tax for fiscal 2023 was $20.35M, a 26.41% decline from fiscal 2022.
- DarioHealth Corp. revenue from contract with customer, including assessed tax for fiscal 2022 was $27.66M, a 34.82% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.18M 10-Q · filed 2026-08-11 | $10.76M 10-Q · filed 2026-08-11 | $15.99M derived: sum of 3 quarters · filed 2026-08-11 | $21.00M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $5.58M 10-Q · filed 2026-05-13 | $10.81M derived: sum of 2 quarters · filed 2026-05-13 | $15.82M derived: sum of 3 quarters · filed 2026-05-13 | $21.19M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $5.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $10.24M derived: sum of 2 quarters · filed 2026-03-19 | $15.61M derived: sum of 3 quarters · filed 2026-08-11 | $22.36M 10-K · filed 2026-03-19 |
| 2025-09-30 | $5.01M 10-Q · filed 2025-11-13 | $10.38M derived: sum of 2 quarters · filed 2026-08-11 | $17.13M 10-Q · filed 2025-11-13 | $24.73M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $5.37M 10-Q · filed 2026-08-11 | $12.12M 10-Q · filed 2026-08-11 | $19.73M derived: sum of 3 quarters · filed 2026-08-11 | $27.15M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $6.75M 10-Q · filed 2026-05-13 | $14.36M derived: sum of 2 quarters · filed 2026-05-13 | $21.78M derived: sum of 3 quarters · filed 2026-05-13 | $28.03M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $7.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $15.03M derived: sum of 2 quarters · filed 2026-03-19 | $21.28M derived: sum of 3 quarters · filed 2026-03-19 | $27.04M 10-K · filed 2026-03-19 |
| 2024-09-30 | $7.42M 10-Q · filed 2025-11-13 | $13.68M derived: sum of 2 quarters · filed 2025-11-13 | $19.44M 10-Q · filed 2025-11-13 | $23.05M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $6.25M 10-Q · filed 2025-08-12 | $12.01M 10-Q · filed 2025-08-12 | $15.63M derived: sum of 3 quarters · filed 2025-08-12 | $19.15M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $5.76M 10-Q · filed 2025-05-14 | $9.37M derived: sum of 2 quarters · filed 2025-05-14 | $12.89M derived: sum of 3 quarters · filed 2025-05-14 | $19.04M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $7.13M derived: sum of 2 quarters · filed 2025-03-10 | $13.29M derived: sum of 3 quarters · filed 2025-03-10 | $20.35M 10-K · filed 2025-03-10 |
| 2023-09-30 | $3.52M 10-Q · filed 2024-11-07 | $9.67M derived: sum of 2 quarters · filed 2024-11-07 | $16.74M 10-Q · filed 2024-11-07 | $23.55M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $6.15M 10-Q · filed 2024-08-08 | $13.22M 10-Q · filed 2024-08-08 | $20.03M derived: sum of 3 quarters · filed 2024-08-08 | $26.63M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $7.07M 10-Q · filed 2024-05-15 | $13.88M derived: sum of 2 quarters · filed 2024-05-15 | $20.48M derived: sum of 3 quarters · filed 2024-05-15 | $26.66M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $6.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $13.41M derived: sum of 2 quarters · filed 2024-03-28 | $19.60M derived: sum of 3 quarters · filed 2024-03-28 | $27.66M 10-K · filed 2024-03-28 |
| 2022-09-30 | $6.61M 10-Q · filed 2023-11-02 | $12.79M derived: sum of 2 quarters · filed 2023-11-02 | $20.85M 10-Q · filed 2023-11-02 | $26.88M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $6.18M 10-Q · filed 2023-08-10 | $14.24M 10-Q · filed 2023-08-10 | $20.27M derived: sum of 3 quarters · filed 2023-08-10 | $25.90M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $8.06M 10-Q · filed 2023-05-11 | $14.09M derived: sum of 2 quarters · filed 2023-05-11 | $19.72M derived: sum of 3 quarters · filed 2023-05-11 | $24.98M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $11.66M derived: sum of 2 quarters · filed 2023-03-09 | $16.92M derived: sum of 3 quarters · filed 2023-03-09 | $20.51M 10-K · filed 2023-03-09 |
| 2021-09-30 | $5.63M 10-Q · filed 2022-11-14 | $10.89M derived: sum of 2 quarters · filed 2022-11-14 | $14.48M 10-Q · filed 2022-11-14 | $16.57M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $5.26M 10-Q · filed 2022-08-15 | $8.86M 10-Q · filed 2022-08-15 | $10.94M derived: sum of 3 quarters · filed 2022-08-15 | $12.98M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $3.60M 10-Q · filed 2022-05-12 | $5.67M derived: sum of 2 quarters · filed 2022-05-12 | $7.72M derived: sum of 3 quarters · filed 2022-05-12 | $9.50M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $4.12M derived: sum of 2 quarters · filed 2022-03-22 | $5.91M derived: sum of 3 quarters · filed 2022-03-22 | $7.58M 10-K · filed 2022-03-22 |
| 2020-09-30 | $2.04M 10-Q · filed 2021-11-15 | $3.83M derived: sum of 2 quarters · filed 2021-11-15 | $5.50M 10-Q · filed 2021-11-15 | $7.29M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $1.79M 10-Q · filed 2021-08-16 | $3.45M 10-Q · filed 2021-08-16 | $5.25M derived: sum of 3 quarters · filed 2021-08-16 | $7.12M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $1.67M 10-Q · filed 2021-05-17 | $3.46M derived: sum of 2 quarters · filed 2021-05-17 | $5.33M derived: sum of 3 quarters · filed 2021-05-17 | $6.98M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $3.67M derived: sum of 2 quarters · filed 2021-03-09 | $5.32M derived: sum of 3 quarters · filed 2021-03-09 | $7.56M 10-K · filed 2021-03-09 |
| 2019-09-30 | $1.87M 10-Q · filed 2020-11-12 | $3.52M derived: sum of 2 quarters · filed 2020-11-12 | $5.76M 10-Q · filed 2020-11-12 | $7.46M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $1.65M 10-Q · filed 2020-08-12 | $3.89M 10-Q · filed 2020-08-12 | $5.59M derived: sum of 3 quarters · filed 2020-08-12 | $7.47M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $2.24M 10-Q · filed 2020-05-12 | $3.94M derived: sum of 2 quarters · filed 2020-05-12 | $5.82M derived: sum of 3 quarters · filed 2020-05-12 | |
| 2018-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $3.58M derived: sum of 2 quarters · filed 2020-03-17 | $7.39M 10-K · filed 2020-03-17 | |
| 2018-09-30 | $1.88M 10-Q · filed 2019-10-28 | $5.69M 10-Q · filed 2019-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |